Compare ETON & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETON | EQBK |
|---|---|---|
| Founded | 2017 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.7M | 993.2M |
| IPO Year | 2018 | 2015 |
| Metric | ETON | EQBK |
|---|---|---|
| Price | $37.07 | $51.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | $39.33 | ★ $51.33 |
| AVG Volume (30 Days) | ★ 406.6K | 161.8K |
| Earning Date | 05-14-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.05 | ★ 0.80 |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | $74.58 |
| Revenue Next Year | $47.23 | $5.11 |
| P/E Ratio | $741.40 | ★ $64.48 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.78 | $36.04 |
| 52 Week High | $39.48 | $51.70 |
| Indicator | ETON | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 59.36 | 68.23 |
| Support Level | $15.77 | $43.99 |
| Resistance Level | $38.62 | $51.48 |
| Average True Range (ATR) | 1.59 | 1.25 |
| MACD | -0.14 | 0.19 |
| Stochastic Oscillator | 47.95 | 89.84 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.